메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 32, Issue 19, 2014, Pages 1987-1989
Multigene panel testing: Planning the next generation of research studies in clinical cancer genetics
Author keywords

[No Author keywords available]
Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DOUBLE STRANDED DNA;
EID: 84905822972     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.56.0474     Document Type: Editorial
Times cited : (37)
References (8)
  • 1
    • 84904750123 scopus 로고    scopus 로고
    • Clinical evaluation of a multigene sequencing panel for hereditary cancer risk assessment
    • Kurian AW, Hare EE, Mills MA, et al: Clinical evaluation of a multigene sequencing panel for hereditary cancer risk assessment. J Clin Oncol 32:2001-2009, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 2001-2009
    • Kurian, A.W.1    Hare, E.E.2    Mills, M.A.3
  • 2
    • 84904430097 scopus 로고    scopus 로고
    • Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer
    • Garziera M, Canzonieri V, Cannizzaro R, et al: Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer. PLoS One 8:e77035, 2013
    • (2013) PLoS One , vol.8
    • Garziera, M.1    Canzonieri, V.2    Cannizzaro, R.3
  • 3
    • 84871217318 scopus 로고    scopus 로고
    • Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - Update 2012
    • Aretz S, Genuardi M, Hes FJ: Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - Update 2012. Eur J Hum Genet 21, 2013
    • (2013) Eur J Hum Genet , pp. 21
    • Aretz, S.1    Genuardi, M.2    Hes, F.J.3
  • 4
    • 84870744620 scopus 로고    scopus 로고
    • CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
    • Weischer M, Nordestgaard BG, Pharoah P, et al: CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 30:4308-4316, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 4308-4316
    • Weischer, M.1    Nordestgaard, B.G.2    Pharoah, P.3
  • 5
    • 18544389716 scopus 로고    scopus 로고
    • CHEK2-Breast Cancer Consortium. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
    • Meijers-Heijboer H, van den Ouweland A, Klijn J, et al: CHEK2-Breast Cancer Consortium. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-59, 2002
    • (2002) Nat Genet , vol.31 , pp. 55-59
    • Meijers-Heijboer, H.1    Van Den Ouweland, A.2    Klijn, J.3
  • 6
    • 77954572243 scopus 로고    scopus 로고
    • Genetic testing in Li-Fraumeni syndrome: Uptake and psychosocial consequences
    • Lammens CR, Aaronson NK, Wagner A, et al: Genetic testing in Li-Fraumeni syndrome: Uptake and psychosocial consequences. J Clin Oncol 28:3008-3014, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 3008-3014
    • Lammens, C.R.1    Aaronson, N.K.2    Wagner, A.3
  • 8
    • 79951581268 scopus 로고    scopus 로고
    • Genetic testing and cancer risk management recommendations by physicians for at-risk relatives
    • Plon SE, Cooper HP, Parks B, et al: Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med 13:148-154, 2011
    • (2011) Genet Med , vol.13 , pp. 148-154
    • Plon, S.E.1    Cooper, H.P.2    Parks, B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.